Cara Williams is a senior drug discovery scientific and R&D leader committed to identifying and developing next-generation breakthrough therapies for IPF.

Her preclinical drug discovery and development experience focuses on delivering both small molecule and large molecule drug candidates into clinical development across multiple therapeutic areas including respiratory diseases such as IPF, COPD, CF and asthma; immunological indications inflammatory disease; gastrointestinal diseases; dermatology; and pain.